Gastroenterology & Hepatology

Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH)

Researchers are invited to submit their abstracts for the "Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH)" track at GASTROENTEROLOGY-2024. This track will focus on the latest advancements in understanding, diagnosing, and treating NAFLD and NASH. Topics of interest include, but are not limited to:

• Pathophysiology and molecular mechanisms underlying NAFLD and NASH.
• Advances in non-invasive diagnostic tools and biomarkers.
• Innovative therapeutic strategies and clinical trials.
• Epidemiological trends and risk factors.
• The role of lifestyle interventions and comorbidities management.

Attendees can expect to delve into comprehensive discussions on the significant burden of NAFLD and NASH on global health. This track will feature expert presentations on groundbreaking research, emerging treatments, and clinical best practices. Participants will gain insights into the latest diagnostic techniques, explore novel therapeutic approaches, and understand the interplay between metabolic disorders and liver health. This track aims to foster collaboration and knowledge exchange to address the growing challenge of NAFLD and NASH in clinical practice.